74,60 €
82,89 €
-10% with code: EXTRA
Pharmacogenetics of acute lymphoblastic leukemia
Pharmacogenetics of acute lymphoblastic leukemia
74,60
82,89 €
  • We will send in 10–14 business days.
Our research focused on investigating the involvement of polymorphisms (C677T and A1298C) of the MTHFR gene in the pharmacogenetics of acute lymphoblastic leukemia (ALL), particularly with high-dose methotrexate (MTX-HD). Despite its proven clinical efficacy, the latter can cause severe toxicity. 41 young children followed for ALL were collected. Genotyping of the two variants was correlated with therapeutic response and pharmacological assays (MTX and homocysteine)While MTHFR C677T is a good m…
  • SAVE -10% with code: EXTRA

Pharmacogenetics of acute lymphoblastic leukemia (e-book) (used book) | bookbook.eu

Reviews

Description

Our research focused on investigating the involvement of polymorphisms (C677T and A1298C) of the MTHFR gene in the pharmacogenetics of acute lymphoblastic leukemia (ALL), particularly with high-dose methotrexate (MTX-HD). Despite its proven clinical efficacy, the latter can cause severe toxicity. 41 young children followed for ALL were collected. Genotyping of the two variants was correlated with therapeutic response and pharmacological assays (MTX and homocysteine)While MTHFR C677T is a good marker of MTX-HD toxicity, A1298C is not. Nevertheless, no correlation between the C677T variant and pharmacokinetic parameters during MTX-HD administrationIn conclusion, despite the debate concerning the existence of a pharmacogenetic marker for the use of MTX in clinical practice, the C677T polymorphism of the MTHFR shows promising results.

EXTRA 10 % discount with code: EXTRA

74,60
82,89 €
We will send in 10–14 business days.

The promotion ends in 7d.04:42:18

The discount code is valid when purchasing from 10 €. Discounts do not stack.

Log in and for this item
you will receive 0,83 Book Euros!?

Our research focused on investigating the involvement of polymorphisms (C677T and A1298C) of the MTHFR gene in the pharmacogenetics of acute lymphoblastic leukemia (ALL), particularly with high-dose methotrexate (MTX-HD). Despite its proven clinical efficacy, the latter can cause severe toxicity. 41 young children followed for ALL were collected. Genotyping of the two variants was correlated with therapeutic response and pharmacological assays (MTX and homocysteine)While MTHFR C677T is a good marker of MTX-HD toxicity, A1298C is not. Nevertheless, no correlation between the C677T variant and pharmacokinetic parameters during MTX-HD administrationIn conclusion, despite the debate concerning the existence of a pharmacogenetic marker for the use of MTX in clinical practice, the C677T polymorphism of the MTHFR shows promising results.

Reviews

  • No reviews
0 customers have rated this item.
5
0%
4
0%
3
0%
2
0%
1
0%
(will not be displayed)